cor2ed
engage checkpoint medical linkedin twitter
bg

GU NURSES CONNECT Update from ESMO 2021 and EONS14 (English)

GU NURSES CONNECT Update from ESMO 2021 and EONS14 (English)

GU NURSES CONNECT has summarised the oncology nursing highlights from ESMO 2021 and the European Oncology Nursing Society (EONS14).

GU NURSES CONNECT has summarised the oncology nursing highlights from ESMO 2021 and the European Oncology Nursing Society (EONS14).

Pablo Peinado

Watch the video and download the slides

Portrait of Pablo Peinado
Pablo Peinado

Research Nurse

Hospital Universitario Virgen de la Victoria

Spain

preview next

time | open 3 min | Sep 2021

This programme was made for you:   your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

Update from ESMO 2021 including EONS14

Hi, my name is Pablo Peinado. I am a Research Nurse Coordinator at the GU Unit in Virgen De La Victoria Hospital, Málaga, south of Spain.

On behalf of GU Nurses CONNECT I would like to comment some relevant abstracts which have been published presently in ESMO '21 and EONS14.

Which abstracts did you select?

After attending both congresses I selected three different abstracts to present today.

The first one, it's from ESMO '21, and it was presented by Dr. Fizazi. The title, it's "Health-related quality of life, pain and safety outcomes in the phase 3 VISION study of Lutetium-PSMA in patients with metastatic castration-resistant prostate cancer".

The second one, it was presented in EONS14 by Urska Kosir. The title is "Delays in screening and diagnosis of cancer during COVID: What can we expect for the next years?"

And the third and last one was presented in EONS14 by Adeline Duflot. 'It's called "Remote monitoring by Nurses Navigators: From experimentation to optimisation of routine practices".

What are the main conclusions?

The abstract presented by Dr. Fizazi evaluating the pain results, health-related quality of life and safety outcomes in the VISION study, has been very positive. We already know about his positive results in overall survival and radiographic progression-free survival, presented in ASCO. But now they've shown a really positive reduction in the risk of pain deterioration compared to baseline and in the risk of quality of life reduction compared to baseline. Apart from that, it has shown a really positive result as well, with the time to the first skeletal event.

Regarding the abstract presented by Urska, in EONS14, she has exposed how the COVID19 pandemic has reduced both the cancer diagnosis, and the urgent oncological referrals. One of the most affected population have been the young cancer patients, showing an important impact in their mental health, due to diagnostic delays, treatment and virtual attention during the pandemic.

Adeline's presentation explains the remote monitoring by nurses navigator going from experimentation to optimisation of routine practices. This study has shown how the nurses navigators have been able to take autonomous decisions in the majority of cases. This improves the use of resources, reduces the oncologic referrals, and improves the patients attention.

What are your take-home messages from EONS14 at ESMO 2021?

After reviewing those abstracts we see the importance of the nurses inside the multidisciplinary team in both with an oncologic patient. Thanks to the new technologies we can have a more personalised attention for our patients, and improve their quality of life.

It is really important for us, as nurses, to fight for these kind of services that have shown such a high benefit for our patients.

On behalf of GU Nurses CONNECT, thank you very much for watching this video, and remember that you can download the slides.

GU NURSES CONNECT Update from ESMO 2021 and EONS14 (English)

GU NURSES CONNECT expert Pablo Peinado has summarised the oncology nursing highlights from ESMO 2021 and the European Oncology Nursing Society (EONS14).

Watch the video and download the slides.

GU NURSES CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.

Other programmes of interest